NOR-OPENSCREEN is the Norwegian node in the EU-OPENSCREEN project and represents the CB and marine bioprospecting expertise in Norway. Presently, Norwegian Life Science areas such as cancer and neuroscience research produce world-class results, and the innovative potential of biomedical research has been increased by cluster organizations like Oslo Cancer Cluster (OCC).
The success of such initiatives will, however, depend heavily on access to drug development expertise. NOR-OPENSCREEN will, in this context, play an important role by providing local access to state-of-the-art compound libraries, high-throughput screening (HTS) facilities and expertise within natural products drug discovery. Furthermore, NOR-OPENSCREEN as a partner in EU-OPENSCREEN will give Norwegian researchers the opportunity to access a much wider range of cutting-edge technologies, thus allowing them to realize scientific projects that would otherwise be out of their reach.
Moreover, NOR-OPENSCREEN will offer specialised expertise making a significant contribution to EU-OPENSCREEN. In particular, our expert knowledge in marine bioprospecting, microbiology screening and metabolomics as well as cell-based HTS flow-cytometry will be important, thus making this expertise available to a broader scientific community.